Cognition Therapeutics (CGTX) Treasury Shares (2020 - 2026)
Cognition Therapeutics (CGTX) posted quarterly Treasury Shares of $4.1 million for Q1 2026, up 14.12% year-over-year from $3.6 million in Q1 2025, and up 67.61% quarter-over-quarter from $2.4 million in Q4 2025.
Cognition Therapeutics (CGTX) Treasury Shares (2020 - 2026) Analysis & Trends
Cognition Therapeutics (CGTX) has reported Treasury Shares for 6 consecutive years, with $4.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Treasury Shares rose 14.12% year-over-year to $4.1 million; the TTM figure through Mar 2026 stood at $4.1 million (up 14.12% YoY), while the FY2025 annual figure was $2.4 million, up 107.48% from the prior year.
- Treasury Shares climbed to $4.1 million in Q1 2026 per CGTX's latest filing, from $2.4 million in the prior quarter.
- Across five years, Treasury Shares topped out at $4.1 million in Q1 2026 and bottomed at $375870.0 in Q1 2023.
- Historically, Treasury Shares has averaged $1.8 million across 4 years, with a median of $1.2 million in 2024.
- Annual changes were most pronounced in 2024 — Treasury Shares soared 218.4% — and 2026, when it rose 14.12%.
- Cognition Therapeutics' Treasury Shares stood at $522155.0 in 2023, then surged by 124.64% to $1.2 million in 2024, then jumped by 107.48% to $2.4 million in 2025, then jumped by 67.61% to $4.1 million in 2026.
- Business Quant data shows CGTX's Treasury Shares at $4.1 million in Q1 2026, $2.4 million in Q4 2025, and $2.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 2.72 Mn |
| 10 | Cognition Therapeutics | 90.18 Mn | 90.18 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.73 Mn |
| Jun 30, 2026 | 3.73 Mn |
| Mar 31, 2026 | 4.08 Mn |
| Mar 31, 2026 | 4.08 Mn |
| Dec 31, 2025 | 2.43 Mn |
| Dec 31, 2025 | 2.43 Mn |
| Sep 30, 2025 | 2.65 Mn |
| Sep 30, 2025 | 2.65 Mn |
| Jun 30, 2025 | 3.67 Mn |
| Jun 30, 2025 | 3.67 Mn |
| Mar 31, 2025 | 3.57 Mn |
| Mar 31, 2025 | 3.57 Mn |
| Dec 31, 2024 | 1.17 Mn |
| Dec 31, 2024 | 1.17 Mn |
| Sep 30, 2024 | 1.20 Mn |
| Sep 30, 2024 | 1.20 Mn |
| Jun 30, 2024 | 1.17 Mn |
| Jun 30, 2024 | 1.17 Mn |
| Mar 31, 2024 | 1.20 Mn |
| Mar 31, 2024 | 1.20 Mn |